Cardiac resynchronization therapy: from creation to evolution--an evidence-based review.

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Congestive heart failure (CHF) is often associated with electrical dyssynchrony, typically left bundle branch block.
• This electrical dyssynchrony leads to mechanical dyssynchrony, reducing overall cardiac efficiency.
• Cardiac resynchronization therapy (CRT) has become a significant treatment for specific CHF patient populations.

Purpose of the Study:

• To evaluate the efficacy of CRT in patients with CHF and electrical dyssynchrony.
• To identify clinical parameters improved by CRT.
• To assess long-term benefits of CRT on cardiac remodeling, hospitalizations, and mortality.

Main Methods:

• Simultaneous left and right ventricular pacing (CRT) was employed.
• Patient selection criteria included ejection fraction <30%, NYHA class III/IV, and QRS width >120 ms.
• Clinical parameters, quality of life, and long-term outcomes were monitored.

Main Results:

• CRT significantly improved 6-minute walk distances, quality-of-life scores, and NYHA functional class.
• Long-term CRT led to reverse remodeling of the failing ventricle.
• Reductions in CHF hospitalizations and mortality were observed, independent of defibrillator therapy.

Conclusions:

• CRT is an effective therapy for selected CHF patients with electrical dyssynchrony.
• While most patients benefit, a subset does not respond to CRT.
• Identifying optimal candidates and timing for CRT initiation requires further investigation.